Trinity Biotech | TRIB - Ebitda

Stock Price
0.64
Daily Change
-0.02 -3.52%
Monthly
5.62%
Yearly
-9.45%
Q2 Forecast
0.62

Trinity Biotech reported $-9.6M in EBITDA for its fiscal quarter ending in December of 2024.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Bayer EUR 1.97B 457M Dec/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
EDAP TMS EUR -4.92M 843K Sep/2025
J&J USD 7.19B 2.32B Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.64B 535M Dec/2025
Surmodics USD 3.43M 1.9M Jun/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Tosoh JPY 39.13B 286M Dec/2024
Trinity Biotech USD -9.6M 7.64M Dec/2024
Veracyte USD 42.31M 2.58M Dec/2025